Combining therapeutic agents to target the immune systems of hepatitis B patients: what do we need to consider?
{{output}}
Introduction: Chronic hepatitis B (CHB) remains a major global health challenge, with functional cure achieved in only a small subset of patients. Current oral antiviral agents effectively suppress viral replication but fail to e... ...
